.decimal Funding: How Much Did They Raise & Key Investors

How Much Did .decimal Raise?
Funding & Key Investors

.decimal has solidified its position as a critical infrastructure provider in the oncology sector, securing a total capital infusion of $975K. This financial trajectory, punctuated by a recent strategic investment of $625K, underscores the company's vital role in the medical device manufacturing landscape. By scaling its operations to support over 150,000 patients, the firm has demonstrated a robust capacity for growth within the highly specialized radiation therapy market.

The company's ability to attract significant debt financing reflects investor confidence in its proprietary, patient-specific manufacturing model. As the healthcare industry shifts toward precision medicine, .decimal remains at the forefront of delivering tailored solutions that optimize clinical outcomes for proton, electron, and photon treatment modalities.

What is .decimal?

.decimal

Manufacturing

Medical Devices & Equipment

.decimal operates as a specialized manufacturer of custom, patient-specific radiation therapy devices, serving a vast network of 949 clinics across the United States. The company distinguishes itself through an on-demand design and delivery framework that has successfully produced over 530,639 devices to date. By integrating advanced manufacturing processes with rigorous material safety standards, .decimal provides essential support to oncology departments, ensuring that radiation delivery is both precise and patient-centric.

The firm's market position is defined by its high-volume, high-precision output, which addresses the complex logistical challenges inherent in modern cancer treatment. By acting as a contract manufacturing partner, .decimal enables clinics to focus on patient care while outsourcing the technical burden of device fabrication to a proven, scalable entity.

How much funding has .decimal raised?

.decimal has raised a total of $975K across 2 funding rounds:

2020

Debt

$350K

2021

Debt

$625K

Debt (2020): $350K with participation from PPP

Debt (2021): $625K led by PPP

Key Investors in .decimal

PPP

Public-Private Partnership

What's next for .decimal?

With the recent influx of capital, .decimal is well-positioned to expand its manufacturing footprint and further refine its digital design workflows. The company's strategic roadmap likely involves deepening its integration with existing clinical software ecosystems to reduce lead times for patient-specific devices. As the demand for personalized radiation therapy continues to rise, the firm is expected to leverage its current liquidity to enhance its material science capabilities and potentially explore new modalities in radiotherapy.

The focus remains on maintaining operational excellence while scaling to meet the needs of an aging population and the increasing prevalence of cancer diagnoses. By prioritizing technological agility and supply chain resilience, .decimal is poised to maintain its leadership in the medical device sector, ensuring that its custom solutions remain the gold standard for clinics nationwide.

See full .decimal company page

See More Financial Insights